Amanda Feeney

1.9k total citations
14 papers, 438 citations indexed

About

Amanda Feeney is a scholar working on Reproductive Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amanda Feeney has authored 14 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amanda Feeney's work include Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Workplace Health and Well-being (2 papers). Amanda Feeney is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Workplace Health and Well-being (2 papers). Amanda Feeney collaborates with scholars based in United Kingdom, United States and Australia. Amanda Feeney's co-authors include Michael Marmot, F North, Jenny Head, Stephen Stansfeld, Michael K. Skinner, Eric Nilsson, Stephen Brunton, A. Mark Fendrick, Richard Colgan and Gregory Scott and has published in prestigious journals such as Journal of Clinical Oncology, Social Science & Medicine and Addiction.

In The Last Decade

Amanda Feeney

14 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Feeney United Kingdom 9 218 78 61 56 44 14 438
Zohreh Keshavarz Iran 11 107 0.5× 132 1.7× 79 1.3× 13 0.2× 83 1.9× 60 583
Connie H. Coralli United States 7 79 0.4× 25 0.3× 32 0.5× 25 0.4× 18 0.4× 14 396
Solbjørg Makalani Myrtveit Sæther Norway 9 46 0.2× 25 0.3× 47 0.8× 50 0.9× 42 1.0× 17 290
Krzysztof Nowosielski Poland 15 69 0.3× 65 0.8× 79 1.3× 56 1.0× 28 0.6× 65 614
Garrett R. Lynch United States 8 48 0.2× 9 0.1× 161 2.6× 29 0.5× 32 0.7× 10 352
Mary Kate Keeter United States 9 72 0.3× 56 0.7× 32 0.5× 18 0.3× 28 0.6× 37 304
Padaphet Sayakhot Australia 9 192 0.9× 26 0.3× 35 0.6× 22 0.4× 117 2.7× 10 485
Shira Hichenberg United States 8 91 0.4× 26 0.3× 92 1.5× 21 0.4× 5 0.1× 10 343
Dana Ketcher United States 12 83 0.4× 15 0.2× 128 2.1× 31 0.6× 15 0.3× 37 366
Jun Lei China 11 30 0.1× 48 0.6× 22 0.4× 40 0.7× 49 1.1× 37 416

Countries citing papers authored by Amanda Feeney

Since Specialization
Citations

This map shows the geographic impact of Amanda Feeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Feeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Feeney more than expected).

Fields of papers citing papers by Amanda Feeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Feeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Feeney. The network helps show where Amanda Feeney may publish in the future.

Co-authorship network of co-authors of Amanda Feeney

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Feeney. A scholar is included among the top collaborators of Amanda Feeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Feeney. Amanda Feeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Mould, Tim, Alison H. Brand, Hans W. Nijman, et al.. (2018). STATEC: A randomised trial of non-selective versus selective adjuvant therapy in high risk apparent stage 1 endometrial cancer.. Journal of Clinical Oncology. 36(15_suppl). TPS5615–TPS5615. 5 indexed citations
3.
Hall, Marcia, Shibani Nicum, Rosemary Lord, et al.. (2018). METRO-BIBF: Phase II, randomised, placebo controlled, multicentre, trial of low dose (metronomic) cyclophosphamide (MCy) with or without nintedanib in relapsed ovarian cancer (ROC).. Journal of Clinical Oncology. 36(15_suppl). 5551–5551. 1 indexed citations
4.
King, Madeleine, Martin R. Stockler, Rachel O’Connell, et al.. (2017). Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer. Quality of Life Research. 27(1). 59–74. 33 indexed citations
5.
Roncolato, Felicia, Florence Joly, Rachel O’Connell, et al.. (2017). Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study. The Oncologist. 22(9). 1117–1124. 18 indexed citations
6.
7.
8.
9.
Feeney, Amanda, Eric Nilsson, & Michael K. Skinner. (2014). Epigenetics and transgenerational inheritance in domesticated farm animals. Journal of Animal Science and Biotechnology. 5(1). 48–48. 49 indexed citations
10.
Feeney, Amanda, Eric Nilsson, & Michael K. Skinner. (2014). Cytokine (IL16) and tyrphostin actions on ovarian primordial follicle development. Reproduction. 148(3). 321–331. 9 indexed citations
11.
McNeish, Iain A., Jonathan A. Ledermann, Lindsay E. James, et al.. (2013). A randomized placebo-controlled trial of saracatinib (AZD0530) plus weekly paclitaxel in platinum-resistant ovarian, fallopian-tube, or primary peritoneal cancer (SaPPrOC).. Journal of Clinical Oncology. 31(15_suppl). 5514–5514. 5 indexed citations
12.
Brunton, Stephen, Richard Colgan, Amanda Feeney, et al.. (2004). Acute exacerbation of chronic bronchitis: a primary care consensus guideline.. PubMed. 10(10). 689–96. 31 indexed citations
13.
Stansfeld, Stephen, et al.. (1995). Sickness absence for psychiatric illness: The Whitehall II study. Social Science & Medicine. 40(2). 189–197. 162 indexed citations
14.
Marmot, Michael, F North, Amanda Feeney, & Jenny Head. (1993). Alcohol consumption and sickness absence: from the Whitehall II study. Addiction. 88(3). 369–382. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zohreh Keshavarz Breakdown of academic impact, for papers by Connie H. Coralli Breakdown of academic impact, for papers by Solbjørg Makalani Myrtveit Sæther Breakdown of academic impact, for papers by Krzysztof Nowosielski Breakdown of academic impact, for papers by Garrett R. Lynch Breakdown of academic impact, for papers by Mary Kate Keeter Breakdown of academic impact, for papers by Padaphet Sayakhot Breakdown of academic impact, for papers by Shira Hichenberg Breakdown of academic impact, for papers by Dana Ketcher Breakdown of academic impact, for papers by Jun Lei
Rankless by CCL
2026